search for


 

The Role of Quantitative Electroencephalogram in the Diagnosis and Subgrouping of Attention-Deficit/Hyperactivity Disorder
J Korean Acad Child Adolesc Psychiatry 2021; 32(3): 85-92
Published online July 1, 2021
© 2021 Korean Academy of Child and Adolescent Psychiatry.

Su Hyun Bong and Jun Won Kim

Department of Psychiatry, Catholic University of Daegu School of Medicine, Daegu, Korea
Correspondence to: Jun Won Kim, Department of Psychiatry, Catholic University of Daegu School of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Korea
Tel: +82-53-650-4786, Fax: +82-53-623-1694, E-mail: f_affection@naver.com
Received April 16, 2021; Revised May 3, 2021; Accepted May 7, 2021.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) leads to functional decline in academic performance, interpersonal relationships, and development in school-aged children. Early diagnosis and appropriate intervention can significantly reduce the functional decline caused by ADHD. Currently, there is no established biological marker for ADHD. Some studies have suggested that various indicators from the quantitative electroencephalogram (QEEG) may be useful biological markers for the diagnosis of ADHD. Until the 2010s, theta/beta ratio (TBR) was a biomarker candidate for ADHD that consistently showed high diagnostic value. However, limitations of TBR have recently been reported. Studies have demonstrated that phase-amplitude coupling, especially theta phase-gamma amplitude coupling, are related to cognitive dysfunction and may assist in the diagnosis of ADHD. As yet, the underlying mechanism is not clearly established, and the clinical efficacy of these biomarkers needs to be proven through well-controlled studies. Based on the heterogeneous characteristics of ADHD, subgrouping through QEEG plays a key role in diagnosis and treatment planning. Sophisticated, welldesigned studies and meta-analyses are necessary to confirm these findings.
Keywords : Attention-deficit/hyperactivity disorder; Electrophysiology; Child psychiatry; Theta/beta ratio; Theta phase-gamma amplitude coupling; Subgroup.
INTRODUCTION

According to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), attention-deficit/hyperactivity disorder (ADHD) is characterized by a persistent lack of attention, hyperactivity, and impulsiveness, causing dysfunction in terms of poor academic performance, interpersonal relationships, and development [1]. In most cultures, the prevalence of ADHD is approximately 5% among children [2]. Among children diagnosed with ADHD, more than 60–85% satisfy the diagnostic criteria of ADHD until adolescence [3,4], and approximately 40–60% of children show symptoms of ADHD even after they become adults [5,6]. However, ADHDrelated functional impairment can be significantly reduced by early diagnosis and treatment [7]. ADHD is thought to be caused by defective brain function. However, the pathophysiology of ADHD is currently unclear. ADHD was first defined as a disease in the earlyDHD was first defined as ‘minimal brain damage (MBD)’ [8]. MBD was based on the hypothesis that congenital problems in children’s brains would lead to symptoms of decreased attention, hyperactivity, and impulsion. Since then, the biological causes of ADHD in children have been actively investigated. The main findings suggest that psychostimulants used to treat ADHD. Psychostimulants, such as methylphenidate and amphetamine, play a role in regulating neurochemicals, such as dopamine and norepinephrine. Researchers are also actively conducting studies to identify the aetiologic or diagnostic markers, including mutation of the dopamine transporter 1 gene (DAT1) or dopamine D4 receptor gene (DRD4) [9], and are investigating decreased activities of the prefrontal cortex via functional magnetic resonance imaging (fMRI) [10]. However, there is currently no established diagnostic biomarker for ADHD. In general, ADHD is diagnosed using DSM-5, and standardized psychological tests, including self-reported scales, intelligence tests, and continuous performance tests [11]. Current methods for the diagnosis of ADHD are criticized for potential overdiagnosis. Additionally, the diagnostic accuracy of ADHD is controversial in patients with comorbidities. Consequently, recent efforts have been made to study various imaging and neurophysiological tests that can be used to diagnose ADHD with increased accuracy.

Electroencephalogram (EEG) is a non-invasive and safe method that does not expose patients to radiation. It is also relatively cheap and has a high temporal resolution. Therefore, it is used in children and adolescents for both clinical and research purposes. In particular, quantitative EEG (QEEG) provides quantitative measures of brain activity through Fourier transformation, unlike other clinical EEGs used for the diagnosis of epilepsy, monitoring of consciousness during anesthesia, and polysomnography. QEEG is actively utilized for the diagnosis, evaluation, and treatment of various mental disorders, such as depression [12], anxiety disorder [13], schizophrenia [14], substance addiction [15], obsessive-compulsive disorder [16], and ADHD [17]. This review describes the theta/beta ratio (TBR), which is the most studied diagnostic marker of QEEG in children and adolescents with ADHD. TBR and theta phase-gamma amplitude coupling (TGC) are both promising biomarkers. Furthermore, the latest knowledge on subgroup classification using QEEG in children with ADHD has also been addressed.

DIAGNOSIS

Theta/beta ratio: supporting group

Patients with ADHD tend to show hypoarousal in their brain function and prominent cortical slowing. These features are indicated by increased slow waves and decreased fast waves in the QEEG [18,19]. Lubar [20] suggested that the TBR is a diagnostic marker that can help diagnose ADHD in children. In QEEG, the brain waves are largely divided into four groups after Fourier transformation according to frequency: delta (1–3 Hz), theta (4–8 Hz), alpha (9–12 Hz), and beta (13–25 Hz). In turn, these are used to measure power.

TBR is the ratio of the theta wave to the beta wave. TBR has been suggested as a method for assessing brain function decline with increased sensitivity compared to evaluating the independent increase and decrease in theta and beta waves, respectively. TBR has mostly been assessed in the vertex, the Cz electrode, in the resting state. In a large-scale study of 482 patients, Monastra et al. [17] reported 86% sensitivity and 98% specificity for the diagnosis of ADHD using TBR in the vertex. Snyder and Hall [21] conducted a meta-analysis of studies on TBR and reported that TBR had a high effect size (approximately 3.08 for the diagnosis of ADHD). Additionally, TBR showed 87% sensitivity and 94% specificity for the diagnosis of ADHD in children and adolescents, suggesting that it is more useful than the self-reported scale [22]. In 2013, the Food and Drug Administration (FDA) of the U.S. authorized the Neuropsychiatric Electroencephalograph-Based ADHD Assessment Aid (NEBA) system to assist in the diagnosis of ADHD. The NEBA system was approved for the diagnosis of ADHD in children and adolescents between the ages of 6 and 17 years. The NEBA system measures TBR. However, the FDA states that ADHD cannot be diagnosed using only the NEBA system and recommends the use of the NEBA system to assist in clinical assessment and diagnosis [23,24]. Theta/beta ratio: opposition group Recent literature has reported negativity against the hypoarousal theory as the cause of ADHD. Some studies have also opposed the idea of using increased TBR to assist in the diagnosis of ADHD. The group suggesting the diagnostic value of TBR has argued that an increase in TBR indicates a hypoarousal condition with reduced brain function and that psychostimulants, such as methylphenidate, are effective in treating ADHD, as the patients are in a hypoarousal condition. In contrast, those opposing the diagnostic value of TBR have suggested that TBR has no significant association with skin conductance levels (SCLs) that reflect the arousal of the brain. They argued that a decrease in alpha power is correlated with an increase in SCLs [25,26]. In a study that compared SCLs in ADHD patients with hypoarousal (high TBR) and hyperarousal (high beta) groups, TBR and beta power were not associated with arousal [27]. Based on these findings, the opposing group stated that TBR is associated with cognitive processing capacity rather than hypoarousal. In a follow-up study, TBR was not significantly correlated with the P300 amplitude, which is closely related to the arousal mechanism. Instead, it was correlated with P300 latency, which is closely related to cognitive processing capacity [28]. Moreover, many studies have shown that TBR does not show any statistical significance and has a low accuracy in distinguishing ADHD from healthy controls [29- 32]. Among these studies, the largest study compared 562 patients with ADHD and 309 healthy controls. In this study, Cz TBR was not significantly different in ADHD patients versus healthy controls [32]. Based on these findings, a meta-analysis by Arns et al. [33] showed that TBR did not have high reliability regarding ADHD diagnosis, and this was caused by the increase in TBR in the control group due to a decreased sleep time and use of electronic devices.

Theta/beta ratio: the debate

In 2015, Snyder, the vice president of the NBA Health Company, who worked in the Research & Development Department, published a large-scale, prospective, triple-blinded, multi-center study, which played a crucial role in TBR being approved by the FDA [34]. In this study, TBR was not used as a simple method to diagnose and distinguish ADHD, but as part of an integrated method that reflected the results of EEG at the discretion of the clinician. TBR was not statistically significant in the diagnosis of ADHD. However, it was highly effective (Cohen’s d, 1.53) in identifying ‘Criterion E’, which referred to the differential diagnosis of ‘other disorders and conditions’ in the DSM-IV-TR-diagnostic criteria. TBR increased the overall accuracy of the diagnosis from 61% to 88%. Snyder reported that the rapid increase in the prevalence of ADHD over time was clearly correlated with a decreased effect size according to the TBR (R2=0.89). This suggests that ADHD has been over-diagnosed in recent years and that ADHD patients with low TBR were being misdiagnosed. Therefore, in patients with other physical or mental disorders that can be mistaken for ADHD, the NEBA system can help in the diagnosis of ADHD at the discretion of the clinician.

The above study was greatly criticized. Loo and Arns [35] pointed out five methodological errors in this study. First, clinicians were instructed to assess ADHD patients as “ADHD- positive” if the primary diagnosis showed clear indications of ADHD. In other cases, the clinicians were instructed to assess as “ADHD-negative.” However, “ADHD negative” included secondary and non-ADHD, which led to errors in the interpretation of the results. Second, “DSM criterion E certainty” is a concept that is not related to the presence or absence of ADHD. The NEBA system had no additional clinical value if not needed to diagnose and distinguish ADHD. Third, discrepancies between the clinicians and the multidisciplinary team were interpreted as ADHD overdiagnosis. However, the two groups did not share the same diagnostic. Such errors were not considered. Fourth, patients who responded well to ADHD medications without side effects were considered to have ADHD. However, this is a circular ADHD argument, and logically flawed. Fifth, the findings of the 2008 study were not replicated in the 2015 study by Snyder et al. [34]. This was explained by an increase in the prevalence of ADHD and subsequent overdiagnosis. However, the findings of Arns et al. [33], showing an increase in TBR in the control group, were not discussed. Therefore, Loo argued that TBR should not be used to diagnose or assist in the diagnosis of ADHD. Furthermore, Arns et al. [36] published an article in 2016, reporting that the FDA approval of the NEBA system was inappropriate. In the article, the authors pointed out the methodological errors and also pointed out the doctrine of the caveat emptor to support their stance that the NEBA system should not be used in clinical settings.

In response, Stein et al. [37] argued that NEBA was not approved by the FDA for the diagnosis of ADHD, but rather as an integration method to assist in diagnosis. Additionally, they highlighted that children with symptoms of ADHD who have a low TBR are likely to have other conditions (head injury, sensory deficit, etc.). Their answers to the errors suggested by Arns et al. [36] are as follows: First, Arns et al. argued that the results on TBR were heterogeneous and inconsistent, and that the effect size decreased. Stein et al. reported that an increase in the prevalence of ADHD led to a large number of false-positive cases. Second, with regard to Arns’ argument on the expertise of FDA reviewers, Stein et al. reported that the reviewers were psychology, psychiatry, neurology, and pediatric experts and that Class III regulatory pathways of FDA require the highest level of evidence. Lastly, to support the reliability of NEBA, the authors reported that NEBA had consistent effects based on research protocols used in 13 independent institutions, even though the prevalence of ADHD varied by region.

Theta/beta ratio: tentative conclusions

Until 2010, TBR was a biomarker candidate for ADHD that consistently showed a high diagnostic value. However, in recent studies, limitations of TBR have been reported. This is, in part, caused by the heterogeneity in ADHD, which is a hallmark of all mental disorders. The universal applicability of TBR is still debated. According to Snyder et al. [34], some children diagnosed with ADHD are misdiagnosed as having other diseases, and that EEG can distinguish ADHD. Therefore, to overcome these limitations, future studies must assess the heterogeneity of ADHD using various biomarkers, including EEG, MRI, and genes.

Theta phase-gamma amplitude coupling

Cross-frequency coupling is an index calculated by combining the neural oscillations of two different frequency domains. This reflects the synchronization between the local and global networks of the brain [38]. In particular, the slower oscillation EEG phase often controls the amplitude, frequency, and the faster EEG phase [39]. Phase-amplitude coupling (PAC) is considered a promising biomarker of mental disorders, and it is expected to infer dysfunction from the whole brain network concept instead of simple measurements of the changes in power of a specific frequency [40]. The most actively studied PAC is TGC, which is closely related to general cognitive functions, including working memory [41,42], language [43], and attention [44]. In particular, the increase in resting TGC in patients with schizophrenia is associated with dysfunction of the default mode network [45,46] and has been actively studied.

TGC is also a promising biological marker of ADHD in children. In a study by Kim et al. [47], children with ADHD showed a significantly lower level of TGC compared to the control group of healthy children, in the resting state. In this study, TGC showed a high accuracy of 71.7% compared to that of TBR (58.7%). In addition, children with ADHD showed a rapid decrease in synchronization when they performed mental arithmetic, in contrast to children without ADHD, who showed no changes in synchronization [48]. This suggested that the normal transition process of suppressing ‘task-negative’ default mode network and activating ‘task-positive’ attentional network does not occur in children with ADHD. Rather, only the ‘task-negative’ default mode network is suppressed in those children. These findings highlighted the potential of TGC as a biological marker to assess problems in attentional set shifting in ADHD.

PAC, including TGC, is an interesting marker for different mental disorders. However, its underlying mechanism has not been fully elucidated. Further research is required to assess the mechanism of PAC as a marker for cognitive function and mental disorders.

SUBGROUPING

Patients with ADHD have varying symptom profiles, responses to medications, progress, and prognosis. Therefore, attempts have been made to subgroup ADHD according to symptoms. In the DSM-IV, subtyping was attempted according to inattention and hyperactivity-impulsivity symptoms. However, the term “subtype” in DSM-IV was changed to “current presentation” in the DSM-5. This was to reflect the results of studies showing that clinical symptoms of ADHD change according to lifestyle and development [49,50]. In recent years, studies have actively assessed the heterogeneity of ADHD through dimensional approaches, including research domain criteria (RDoC) and hierarchical taxonomy of psychopathology (HiTOP) to overcome the limitations of the DSM diagnosis systems based on clinical symptoms. In particular, machine learning studies have used MRI to subgroup and analyze the characteristics of ADHD [51-53] and these have made rapid progress. Similarly, QEEG has also been suggested as a promising research tool for ADHD subgrouping [54].

In early studies, three subgroups of ADHD were observed using QEEG [55]. The first group was a maturational lag type with increased slow waves and decreased fast waves. During the normal transition from childhood to adolescence, slow waves decreased and fast waves increased in EEG. The maturational lag type suggests that brain development is slower in children with ADHD than in children without ADHD. Differences have been observed in the maturational lag type when comparing children of the same age with and without ADHD, but not when compared with children of younger ages. The second group was the hypoarousal type. In this group, both the theta and beta waves were increased. This translated into an increased TBR. Previous studies that reported on ADHD with increased TBR might have been biased and included many cases of this hypoarsoual ADHD type. This subgroup is associated with thalamo-cortical dysrhythmia and shows a similar pattern on the QEEG, which is also observed in different mental disorders [56]. In a recent study, 35% of children with ADHD showed this hypoarousal type with an increased TBR and were clearly distinguished from other subgroups [57]. The third subgroup was the hyperarousal type, observed in 20% of the children with ADHD. It is characterized by hyperactive beta waves and is more common in boys. This subgroup leads to more comorbidities and increased complaints of temper tantrums [58]. This subgroup also showed a poor response to medication [59]. In a recent study, Clarke et al. [60] included subjects with ADHD who had comorbid mental disorders (n=155) and observed a fourth subtype, with increased alpha waves. This group showed a significantly high response to the confused or fog’ state on the Child Behavior Checklist and demonstrated increased ritualistic behaviors and hyperactivity.

Fig. 1. Spectral Power Profiles for EEG-based subgroups. Relative power in the parietal region (P3, Pz, and P4) across the frequency bands for each of the five empirically defined subgroups. Each group is named for the frequency band where the power is significantly elevated above the other clusters. Degrees of freedom for EEG analyses F[4775]. Post hoc results (p<0.05) for each frequency band were located above the spectral elevation for each frequency band. EEG: electroencephalogram. Adapted from Loo et al. J Child Psychol Psychiatr 2018;59:223- 231, with permission of John Wiley and Sons [61].

Loo et al. [61] analyzed the QEEG of 781 participants (620 ADHD and 161 control) and classified them into five classes. The five classes were named based on the frequency of the most dominant EEG: delta (30%), theta (23%), alpha (20%), beta (7%), and no spectral elevation (NSE; 20%). The authors observed that the subgroup with prominent delta and theta waves was associated with disruptive behavior and cognitive dysfunction, while those with prominent alpha and beta waves were associated with emotional dysregulation and internalizing behavior. Additionally, the authors stated that in previous studies, comorbid mood disorders were excluded, which led to subgroups with prominent delta and theta waves and subsequently high TBR. The NSE subgroup, which showed no increase in the power spectrum at any frequency band, showed relatively fewer behavioral and cognitive function problems. This subgroup was observed in all ADHD and typically developing control groups. This suggests that the clinical diagnosis of ADHD may show no specific abnormalities on EEG.

Byeon et al. [62] also confirmed the heterogeneity of ADHD by subgrouping using QEEG. In this study, 74 children were divided into three groups: ADHD, not other specified (NOS), and neurotypical (NT), and cluster analysis further divided the participants into four subgroups. In addition to the maturational lag and hypoarousal types, a new type with increased alpha waves was observed. This subgroup contained the highest proportion of NOS (ADHD 30%, NOS 59%, NT 11%), suggesting that childhood depression showed similar symptoms to ADHD and was misdiagnosed.

Fig. 2. The difference in topography between the 4 subtypes divided by cluster analysis of quantitative electroencephalogram.
Adapted from Byeon et al. PLOS ONE 2020;15:e0242566 [62].

Based on the findings of studies that subgrouped ADHD using QEEG, ADHD is heterogeneous, and several subtypes can be identified. In particular, the subtype with increased alpha waves. Alpha is presumed to be associated with mood (depression and emotional dysregulation). This is also consistent with the statement of Snyder et al. [34] that low TBR is not pure ADHD, but a condition or comorbidity that has symptoms similar to ADHD. Further research is required regarding the subgroups of ADHD, and these studies are important for clinical diagnosis and treatment of ADHD.

Characteristics of studies on QEEG subgroups in ADHD

Study (years) N Clinical characteristics Number of subgroups Results


ADHD Control Age Male (%)
Clarke et al. [55] (2001) 184 40 8-12 100 3 Cluster 1 (hypoarousal type): 42.3%
Cluster 2 (maturational lag type): 37.5%
Cluster 3 (hyperarousal type): 20.2%
Clarke et al. [60] (2011) 155 109 7-13 100 5 Cluster 1 (hyperarousal type): 23.2%
Cluster 2* (hypoarousal type): 11%
Cluster 3 (maturational lag type): 24.5%
Cluster 4* (hypoarousal type): 24.5%
Cluster 5: 16.8%
*Cluster 2 and 4 has a same QEEG profile. Total 35.5%
Loo et al. [61] (2018) 620 161 6-18 59 5 Delta group: 30%
Theta group: 23%
Alpha group: 20%
Beta group: 7%
No spectral elevation group: 20%
Byeon et al. [62] (2020) 59 (32; ADHD NOS) 15 7-12 78 4 Cluster 1 (maturational lag type): ADHD (46%), NOS (33%), NT (21%)
Cluster 2 (childhood depression): ADHD (30%), NOS (59%), NT (11%)
Cluster 3 (hypoarousal type): ADHD (47%), NOS (40%), NT (13%)
Cluster 4 (relatively normal): ADHD (13%), NOS(25%), NT (62%)

ADHD: attention deficit/hyperactivity disorder, NOS: not other specified, NT: neurotypical, QEEG: quantitative electroencephalogram


CONCLUSION

TBR is the most studied QEEG diagnostic index for ADHD; however, recent studies have argued that TBR is not a valid biological marker, as the control group showed increased TBR and heterogeneity of ADHD. Therefore, new indices, such as TGC, would be useful for diagnosing ADHD, and further studies on such new indices are necessary. A dimensional approach, including RDoC and HiTOP, may help assess the heterogeneity of ADHD, and more specific studies through subgrouping will increase our understanding of ADHD. Systematic and large-scale studies or meta-analyses are necessary to demonstrate a high level of evidence for the use of QEEG in ADHD diagnosis.

Acknowledgments

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Ministry of Science, ICT & Future Planning (NRF-2018R1C1B5041143).

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Author Contributions

Conceptualization: Su Hyun Bong, Jun Won Kim. Data curation: Su

Hyun Bong, Jun Won Kim. Funding acquisition: Jun Won Kim. Investigation: Su Hyun Bong, Jun Won Kim. Project administration: Su Hyun Bong, Jun Won Kim. Supervision: Jun Won Kim. Validation: Su Hyun Bong, Jun Won Kim. Visualization: Su Hyun Bong, Jun Won Kim. Writing— original draft: Su Hyun Bong. Writing—review & editing: Jun Won Kim.

References
  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association;2013.
    CrossRef
  2. Sayal K, Prasad V, Daley D, Ford T, Coghill D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018;5:175-186.
    CrossRef
  3. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1996;35:343-351.
    Pubmed CrossRef
  4. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546-557.
    Pubmed CrossRef
  5. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289.
    Pubmed CrossRef
  6. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry 2009;65:46-54.
    Pubmed KoreaMed CrossRef
  7. Sonuga-Barke EJ, Halperin JM. Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention? J Child Psychol Psychiatry 2010;51:368-389.
    Pubmed CrossRef
  8. Ross DM, Ross SA. Hyperactivity: research, theory, and action. New York, NY: Wiley;1976.
  9. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126:51-90.
    Pubmed CrossRef
  10. Hart H, Radua J, Mataix-Cols D, Rubia K. Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev 2012;36:2248-2256.
    Pubmed CrossRef
  11. Lee MS, Park SB, Kim GM, Kim HJ, Park S, Kim Y, et al. The revised Korean practice parameter for the treatment of attention-deficit hyperactivity disorder (II)-diagnosis and assessment. J Korean Acad Child Adolesc Psychiatry 2017;28:58-69.
    CrossRef
  12. Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res 2010;44:90-98.
    Pubmed KoreaMed CrossRef
  13. Jokić-Begić N, Begić D. Quantitative electroencephalogram (qEEG) in combat veterans with post-traumatic stress disorder (PTSD). Nord J Psychiatry 2003;57:351-355.
    Pubmed CrossRef
  14. Kim JW, Lee YS, Han DH, Min KJ, Lee J, Lee K. Diagnostic utility of quantitative EEG in unmedicated schizophrenia. Neurosci Lett 2015;589:126-131.
    Pubmed CrossRef
  15. Alper KR, Prichep LS, Kowalik S, Rosenthal MS, John ER. Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 1998;19:1-9.
    CrossRef
  16. Tot S, Ozge A, Cömelekoğlu U, Yazici K, Bal N. Association of QEEG findings with clinical characteristics of OCD: evidence of left frontotemporal dysfunction. Can J Psychiatry 2002;47:538-545.
    Pubmed CrossRef
  17. Monastra VJ, Lubar JF, Linden M, VanDeusen P, Green G, Wing W, et al. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: an initial validation study. Neuropsychology 1999;13:424-433.
    Pubmed CrossRef
  18. Barry RJ, Clarke AR. Spontaneous EEG oscillations in children, adolescents, and adults: typical development, and pathological aspects in relation to AD/HD. J Psychophysiol 2009;23:157-173.
    CrossRef
  19. Mann CA, Lubar JF, Zimmerman AW, Miller CA, Muenchen RA. Quantitative analysis of EEG in boys with attention-deficit-hyper-activity disorder: controlled study with clinical implications. Pediatr Neurol 1992;8:30-36.
    CrossRef
  20. Lubar JF. Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders. Biofeedback Self Regul 1991;16:201-225.
    Pubmed CrossRef
  21. Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol 2006;23:440-455.
    Pubmed CrossRef
  22. Snyder SM, Quintana H, Sexson SB, Knott P, Haque AF, Reynolds DA. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res 2008;159:346-358.
    Pubmed CrossRef
  23. FDA. De novo classification request for neuropsychiatric EEG-based assessment aid for ADHD (NEBA) system. [updated 2013; cited 2021 Apr 15]. Available from URL: www.accessdata.fda.gov/cdrh_docs/reviews/K112711.pdf.
  24. FDA. FDA permits marketing of first brain wave test to help assess children and teens for ADHD. [updated 2013 Jul 15;cited 2021 Apr 15]. Available from URL: www.fda.gov/NewsEvents/News-room/PressAnnouncements/ucm360811.htm.
  25. Barry RJ, Clarke AR, Johnstone SJ, Brown CR. EEG differences in children between eyes-closed and eyes-open resting conditions. Clin Neurophysiol 2009;120:1806-1811.
    Pubmed CrossRef
  26. Barry RJ, Clarke AR, Johnstone SJ, McCarthy R, Selikowitz M. Electroencephalogram theta/beta ratio and arousal in attention-deficit/hyperactivity disorder: evidence of independent processes. Biol Psychiatry 2009;66:398-401.
    Pubmed CrossRef
  27. Clarke AR, Barry RJ, Dupuy FE, McCarthy R, Selikowitz M, Johnstone SJ. Excess beta activity in the EEG of children with attention-deficit/hyperactivity disorder: a disorder of arousal? Int J Psychophysiol 2013;89:314-319.
    Pubmed CrossRef
  28. Clarke AR, Barry RJ, Karamacoska D, Johnstone SJ. The EEG theta/beta ratio: a marker of arousal or cognitive processing capacity? Appl Psychophysiol Biofeedback 2019;44:123-129.
    Pubmed CrossRef
  29. Coolidge FL, Starkey MT, Cahill BS. Comparison of a parent-rated DSM-IV measure of attention-deficit/hyperactivity disorder and quantitative EEG parameters in an outpatient sample of children. J Clin Neurophysiol 2007;24:348-351.
    Pubmed CrossRef
  30. Ogrim G, Kropotov J, Hestad K. The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates. Psychiatry Res 2012;198:482-488.
    Pubmed CrossRef
  31. Buyck I, Wiersema JR. Resting electroencephalogram in attention deficit hyperactivity disorder: developmental course and diagnostic value. Psychiatry Res 2014;216:391-397.
    Pubmed CrossRef
  32. Loo SK, Cho A, Hale TS, McGough J, McCracken J, Smalley SL. Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J Atten Disord 2013;17:384-392.
    Pubmed CrossRef
  33. Arns M, Conners CK, Kraemer HC. A decade of EEG theta/beta ratio research in ADHD: a meta-analysis. J Atten Disord 2013;17:374-383.
    Pubmed CrossRef
  34. Snyder SM, Rugino TA, Hornig M, Stein MA. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain Behav 2015;5:e00330.
    Pubmed KoreaMed CrossRef
  35. Loo SK, Arns M. Should the EEG-based theta to beta ratio be used to diagnose ADHD? The ADHD Report 2015;23:8-13.
    CrossRef
  36. Arns M, Loo SK, Sterman MB, Heinrich H, Kuntsi J, Asherson P, et al. Editorial perspective: how should child psychologists and psychiatrists interpret FDA device approval? Caveat emptor. J Child Psychol Psychiatry 2016;57:656-658.
    Pubmed CrossRef
  37. Stein MA, Snyder SM, Rugino TA, Hornig M. Commentary: objective aids for the assessment of ADHD-further clarification of what FDA approval for marketing means and why NEBA might help clinicians. A response to Arns et al. (2016). J Child Psychol Psychiatry 2016;57:770-771.
    Pubmed CrossRef
  38. Canolty RT, Knight RT. The functional role of cross-frequency coupling. Trends Cogn Sci 2010;14:506-515.
    Pubmed KoreaMed CrossRef
  39. Jerath R, Beveridge C, Jensen M. On the hierarchical organization of oscillatory assemblies: layered superimposition and a global bio-electric framework. Front Hum Neurosci 2019;13:426.
    Pubmed KoreaMed CrossRef
  40. Sacks DD, Schwenn PE, McLoughlin LT, Lagopoulos J, Hermens DF. Phaseamplitude coupling, mental health and cognition: implications for adolescence. Front Hum Neurosci 2021;15:622313.
    Pubmed KoreaMed CrossRef
  41. Kaminski M, Brzezicka A, Kaminski J, Blinowska KJ. Coupling between brain structures during visual and auditory working memory tasks. Int J Neural Syst 2019;29:1850046.
    Pubmed CrossRef
  42. Axmacher N, Henseler MM, Jensen O, Weinreich I, Elger CE, Fell J. Cross-frequency coupling supports multi-item working memory in the human hippocampus. Proc Natl Acad Sci U S A 2010;107:3228-3233.
    Pubmed KoreaMed CrossRef
  43. Doesburg SM, Vinette SA, Cheung MJ, Pang EW. Theta-modulated gamma-band synchronization among activated regions during a verb generation task. Front Psychol 2012;3:195.
    Pubmed KoreaMed CrossRef
  44. Gonzalez-Trejo E, Mögele H, Pfleger N, Hannemann R, Strauss DJ. Electroencephalographic phase-amplitude coupling in simulated driving with varying modality-specific attentional demand. IEEE Trans Hum Mach Syst 2019;49:589-598.
    CrossRef
  45. Lee TH, Kim M, Hwang WJ, Kim T, Kwak YB, Kwon JS. Relationship between resting-state theta phase-gamma amplitude coupling and neurocognitive functioning in patients with first-episode psychosis. Schizophr Res 2020;216:154-160.
    Pubmed CrossRef
  46. Won GH, Kim JW, Choi TY, Lee YS, Min KJ, Seol KH. Theta-phase gamma-amplitude coupling as a neurophysiological marker in neuroleptic-naïve schizophrenia. Psychiatry Res 2018;260:406-411.
    Pubmed CrossRef
  47. Kim JW, Lee J, Kim BN, Kang T, Min KJ, Han DH, et al. Theta-phase gamma-amplitude coupling as a neurophysiological marker of attention deficit/hyperactivity disorder in children. Neurosci Lett 2015;603:25-30.
    Pubmed CrossRef
  48. Kim JW, Kim BN, Lee J, Na C, Kee BS, Min KJ, et al. Desynchronization of theta-phase gamma-amplitude coupling during a mental arithmetic task in children with attention deficit/hyperactivity disorder. PLoS One 2016;11:e0145288.
    Pubmed KoreaMed CrossRef
  49. Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley SL, Mc-Gough JJ, et al. ADHD symptoms and subtypes: relationship between childhood and adolescent symptoms. J Am Acad Child Adolesc Psychiatry 2007;46:1605-1613.
    Pubmed CrossRef
  50. Epstein JN, Loren RE. Changes in the definition of ADHD in DSM-5: subtle but important. Neuropsychiatry (London) 2013;3:455-458.
    Pubmed KoreaMed CrossRef
  51. Lecei A, van Hulst BM, de Zeeuw P, van der Pluijm M, Rijks Y, Durston S. Can we use neuroimaging data to differentiate between subgroups of children with ADHD symptoms: a proof of concept study using latent class analysis of brain activity. Neuroimage Clin 2019;21:101601.
    Pubmed KoreaMed CrossRef
  52. Qureshi MN, Min B, Jo HJ, Lee B. Multiclass classification for the differential diagnosis on the ADHD subtypes using recursive feature elimination and hierarchical extreme learning machine: structural MRI study. PLoS One 2016;11:e0160697.
    Pubmed KoreaMed CrossRef
  53. Qian X, Castellanos FX, Uddin LQ, Loo BRY, Liu S, Koh HL, et al. Large-scale brain functional network topology disruptions underlie symptom heterogeneity in children with attention-deficit/hyperactivity disorder. Neuroimage Clin 2019;21:101600.
    Pubmed KoreaMed CrossRef
  54. Karalunas SL, Nigg JT. Heterogeneity and subtyping in attention-deficit/hyperactivity disorder-considerations for emerging research using person-centered computational approaches. Biol Psychiatry 2020;88:103-110.
    Pubmed CrossRef
  55. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2001;112:2098-2105.
    CrossRef
  56. Llinás RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thala-mocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A 1999;96:15222-15227.
    Pubmed KoreaMed CrossRef
  57. Bussalb A, Collin S, Barthélemy Q, Ojeda D, Bioulac S, Blasco-Fontecilla H, et al. Is there a cluster of high theta-beta ratio patients in attention deficit hyperactivity disorder? Clin Neurophysiol 2019;130:1387-1396.
    Pubmed CrossRef
  58. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. Excess beta activity in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Res 2001;103:205-218.
    CrossRef
  59. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2002;113:194-205.
    CrossRef
  60. Clarke AR, Barry RJ, Dupuy FE, Heckel LD, McCarthy R, Selikowitz M, et al. Behavioural differences between EEG-defined subgroups of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2011;122:1333-1341.
    Pubmed CrossRef
  61. Loo SK, McGough JJ, McCracken JT, Smalley SL. Parsing hetero-geneity in attention-deficit hyperactivity disorder using EEG-based subgroups. J Child Psychol Psychiatry 2018;59:223-231.
    Pubmed KoreaMed CrossRef
  62. Byeon J, Choi TY, Won GH, Lee J, Kim JW. A novel quantitative electroencephalography subtype with high alpha power in ADHD: ADHD or misdiagnosed ADHD? PLoS One 2020;15:e0242566.
    Pubmed KoreaMed CrossRef


July 2021, 32 (3)
Full Text(PDF) Free
PubMed Central
Google Scholar Search

Social Network Service
Services
Close ✕


Stats or Metrics
  • CrossRef (0)
  • View (165)
  • Download (120)

Author ORCID Information

Funding Information